⌘K

Login Start Free

Home/Filings/4/0001140361-10-042118

4//SEC Filing

Kivel Richard 4

Accession 0001140361-10-042118

CIK 0001228627other

View on SEC.gov Company Profile

Filed

Oct 24, 8:00 PM ET

Accepted

Oct 25, 11:02 AM ET

Size

5.8 KB

Accession

0001140361-10-042118

Insider Transaction Report

Form 4

Period: 2010-09-17

REXAHN PHARMACEUTICALS, INC.RNN

Director

Transactions

Award
Stock Options (right-to-buy)
2010-09-17+20,000→ 20,000 total
Exercise: $1.19Exp: 2020-09-17→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]These options vest and become exercisable in full on September 17, 2011.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

Entity typeother

Related Parties

1

filerCIK 0001503757

Filing Metadata

Form type: 4
Filed: Oct 24, 8:00 PM ET
Accepted: Oct 25, 11:02 AM ET
Size: 5.8 KB

View on SEC.gov